MRE plus Fib-4 prove highly accurate in liver fibrosis detection
Researchers have found that coupling image-based and serum-based biomarkers achieves a higher diagnostic accuracy in detecting stage 2...
Sep 15, 20203 min read
Hello from our new imaging core lab
Resoundant Expands Services Offerings to Support Use of Quantitative Imaging Biomarkers in Clinical Trials Kay Pepin, PhD is Manager,...
Aug 26, 20202 min read
It’s official – we’re in the core lab business
Resoundant Expands Services Offerings to Support Use of Quantitative Imaging Biomarkers in Clinical Trials Resoundant, Inc. announced...
Aug 20, 20203 min read
MRE Top Noninvasive Test for Confirming NASH Fibrosis
Abstract Background: There has been an increased interest in the use of noninvasive tests (NITs) to identify advanced liver fibrosis in...
Aug 19, 20201 min read
Resoundant Expands Its Research Services Footprint
Company to offer advanced MRE and PDFF biomarkers for NAFLD/NASH clinical trials
Aug 12, 20203 min read
Resoundant Appoints Roderic I. Pettigrew to Board of Directors
Rochester, MN, USA—Resoundant, Inc. announced today the appointment of Roderic I. Pettigrew, MD, PhD to its Board of Directors. "We’re...
Apr 23, 20203 min read
